Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated November 18, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on November 17, 2025, acting through BNP Paribas SA as the broker. The transaction is part of an existing buyback programme established under a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics
The filing focuses exclusively on capital structure and share repurchase activity. It does not contain revenue, profit, cash flow, margin, or debt metrics.
- Shares Purchased (Nov 17, 2025): 170,000 ordinary shares.
- Price Range: Lowest 1,781.00p; Highest 1,800.50p.
- Volume-Weighted Average Price (VWAP): 1,789.39p.
- Cumulative Buyback (since Sept 30, 2025): 9,170,000 ordinary shares.
- Treasury Shares Held: 256,634,844 ordinary shares.
- Shares in Issue (excluding Treasury): 4,058,796,266 ordinary shares.
- Total Voting Rights: 4,058,796,266.
- Treasury Voting Rights Percentage: 6.32%.
Material Changes
Following the November 17 purchase, the company's treasury shareholding increased to 256,634,844 shares. The total number of voting rights remains 4,058,796,266. The percentage of voting rights attributable to treasury shares is confirmed at 6.32%. The filing notes that the purchase was executed across three trading venues: BATE (19,462 shares), CHIX (48,872 shares), and XLON (101,666 shares).
Guidance, Outlook, and Risks
The filing contains no financial guidance, operational outlook, or management commentary regarding business performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the "Risk Factors" section of the 2024 Annual Report on Form 20-F and the Q3 2025 Results. No specific new risks or contingencies are disclosed in this document.
Investor Verification Checklist
- Verify the total cumulative buyback volume of 9,170,000 shares since September 30, 2025.
- Confirm the updated treasury share count of 256,634,844 and the 6.32% voting rights attribution.
- Review the non-discretionary agreement terms announced on September 30, 2025, to understand the remaining capacity of the buyback programme.
- Check the 2024 Form 20-F and Q3 2025 Results for the risk factors referenced in the cautionary statement.